Two cases of delayed onset of immune‐related adverse events after discontinuation of nivolumab in patients with metastatic renal cell cancer

Two cases of delayed onset of immune‐related adverse events after discontinuation of nivolumab in patients with metastatic renal cell cancer

Introduction Delayed onset of immune‐related adverse events following immune‐checkpoint inhibitor discontinuation is underrecognized because of little available evidence. Case presentation A 50‐year‐old man with metastatic renal cell carcinoma (Case 1) and 58‐year‐old woman with renal cell carcinoma...

Full description

Bibliographic Details
Main Authors: Yasutomo Nakai, Tomoyuki Otsuka, Takako Inoue, Takatoshi Nawa, Koji Hatano, Yoshiyuki Yamamoto, Akira Nagahara, Masashi Nakayama, Ken‐ichi Kakimoto, Kazuo Nishimura
Format: Article
Language:English
Published: Wiley 2021-09-01
Series:IJU Case Reports
Subjects:
delayed onset
immune‐checkpoint inhibitor
immune‐related adverse events
renal cell carcinoma
Online Access:https://doi.org/10.1002/iju5.12338

Internet

https://doi.org/10.1002/iju5.12338

Similar Items